LabCorp
LH
#1013
Rank
$19.73 B
Marketcap
$236.00
Share price
1.47%
Change (1 day)
8.96%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

P/E ratio for LabCorp (LH)

P/E ratio as of December 2024 (TTM): 31.4

According to LabCorp's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 31.3703. At the end of 2022 the company had a P/E ratio of 14.5.

P/E ratio history for LabCorp from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202214.532.24%
202111.00.17%
202011.0-36.48%
201917.338.49%
201812.512.69%
201711.1-29.3%
201615.6-36.37%
201524.660.04%
201415.425.8%
201312.20.27%
201212.2-14.32%
201114.22.4%
201013.910.41%
200912.6-3.89%
200813.1-17.95%
200715.9-11.85%
200618.113.37%
200516.0-3.09%
200416.516.16%
200314.227.05%
200211.2-58.41%
200126.8

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
23.5-25.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-19.8-162.99%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.11-103.54%๐Ÿ‡บ๐Ÿ‡ธ USA
45.5 45.10%๐Ÿ‡บ๐Ÿ‡ธ USA
30.5-2.91%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.